Alturas Analytics, Inc. is a contract research organization providing personalized MS/MS bioanalytical services to the pharma and biotech industries worldwide, and was founded in 2000 with a core team of bioanalytical experts dedicated to LC-MS/MS.Robin Woods, President and co-founder, previously established and operated two environmental testing laboratories which still operate successfully today. With a decade of extensive contract laboratory experience, Robin turned her focus to bioanalysis with the formation of Alturas Analytics, Inc. Shane Needham, Ph.D., an active contributor in the scientific community and former scientist at Pfizer, brought a history of LC-MS/MS bioanalytical experience. The combination of business and operational insight along with scientific expertise and pharma industry experience created a foundation that has successfully led Alturas through 20 years of sustained organic growth. Our state-of-the-art purpose-built laboratory houses the most technically advanced MS/MS instrumentation. Streamlined processes and software automation means we have the capacity to provide the highest levels of quality, service, and rapid turnaround for sample analysis and data delivery.
Over the past two decades, Alturas Analytics has developed a scientific team with extensive knowledge that supports programs from drug discovery and development to IND submissions and new drug approvals. With a turnover rate of less than 5% annually, our sponsors can have the confidence of working with a consistent team throughout the life of each project. Today, Alturas continues to lead the industry into the future, contributing to the latest technologies and developing novel methodologies.